Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Pharmaceutical Research|December 17, 2013
Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studiesE Markoutsa, K Papadia, A D Giannou, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Synthesis of 1,2,4-triazole derivatives: binding properties on endothelin receptorsL Salerno, F Guerrera, M Modica, et al.Journal of Medicinal Chemistry|July 7, 1995
Novel, potent, and selective 5-HT3 receptor antagonists based on the arylpiperazine skeleton: synthesis, structure, biological activity, and comparative molecular field analysis studiesM Anzini, A Cappelli, S Vomero, et al.Epilepsy Research|July 1, 1993
GABAA receptor impairment in the genetic absence epilepsy rats from Strasbourg (GAERS): an immunocytochemical and receptor binding autoradiographic studyR Spreafico, T Mennini, L Danober, et al.Pharmacological Research|June 8, 2001
1,5-Benzodiazepine tricyclic derivatives exerting anti-inflammatory effects in mice by inhibiting interleukin-6 and prostaglandinE(2)productionP Fruscella, M Sottocorno, M Di Braccio, et al.Journal of Medicinal Chemistry|November 27, 1992
Pyrrolobenzodiazepines and related systems. 2. Synthesis and biological properties of isonoraptazepine derivativesS Massa, M Artico, A Mai, et al.Journal of Medicinal Chemistry|November 14, 1997
Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structureG Campiani, A Cappelli, V Nacci, et al.Journal of Medicinal Chemistry|September 28, 1998
New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structureG Campiani, V Nacci, S Bechelli, et al.Journal of Medicinal Chemistry|November 2, 1999
Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studiesG Campiani, E Morelli, S Gemma, et al.Journal of Medicinal Chemistry|December 14, 2001
Characterization of the 1H-cyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization propertiesG Campiani, E Morelli, V Nacci, et al.Pageof 4